Back to search

Article

Considering Real-World Effectiveness of GLP-1RA Persistence and Outcomes for Weight loss regimes.

2025-08-20

Abstract excerpt

not-yet-known not-yet-known not-yet-known unknown This letter thanks Samuels et al. for the insightful information shared in their article about the real-world efficacy of semaglutide and tirzepatide in an academic obesity clinic. Appreciating the successful cohort study, we mention a few methodological and interpretative issues that should be discussed. Issues are raised regarding generalizability of results...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
463c998e-178a-568a-9b43-da34d5a2856e
DOI
10.22541/au.175565534.46206657/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Considering Real-World Effectiveness of GLP-1RA Persistence and Outcomes for Weight loss regimes.DOI 10.22541/au.175565534.46206657/v1
Endogenous Incretin Secretagogue Compositions as a Mechanistic Class Versus Pharmacological Incretin Receptor Agonists for Weight Reduction in Overweight Adults: A Real-World Observational Cohort Analysis of a Nutraceutical Composition (Trimsulin) and Comparison with Published Outcomes for Semaglutide and TirzepatideSemantic proximity
Real-World Weight Loss and Telehealth Platform Utilization Patterns of Long-Term GLP-1 Receptor Agonist Treatment of self pay patients : A Retrospective AnalysisSemantic proximity
Real-World Effectiveness, Safety, and Use Patterns of GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes: A Nationwide Multicentre Community Pharmacy StudySemantic proximity
Exploring real-world user experiences of GLP-1 receptor agonist therapy for obesity treatment, and barriers and motivators to adherenceSemantic proximity
Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity
Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity
Current status of anti-obesity medications and performance, an EHR based surveySemantic proximity
Are Semaglutide and Tirzepatide Cost-Effective for Weight Management? A Systematic Review and Meta-analysisSemantic proximity
Clinical efficacy landscaping in genetic obesity: A meta-analysis in Prader Willi syndrome (PWS)Semantic proximity
Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight lossSemantic proximity
Oral Wegovy Broadens Care Continuum Across First-Time GLP-Starters, High Cardiometabolic Burden GLP-Switchers, and Medicare-Age PatientsSemantic proximity
Patient Adherence to a Real-World Digital Asynchronous Weight-Loss Program in Australia That Combines Behavioural and GLP-1 RA Therapy: A Mixed Methods StudySemantic proximity
Select a neighboring publication to make it the new centre.